We have collected information about Exubera Pulmonary Insulin Delivery System for you. Follow the links to find out details on Exubera Pulmonary Insulin Delivery System.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925008/
The Exubera Device. Exubera (INH) is a novel inhaled insulin delivery system that has been developed for prandial insulin use in patients with type 1 or type 2 diabetes. The INH system has 3 main components: a dry powder formulation of human insulin, packaged in foil blisters for long-term stability; the insulin inhaler device with a holding chamber that facilitates appropriate and consistent ...Author: Priscilla A. Hollander
https://www.ncbi.nlm.nih.gov/pubmed/17435648
Mar 05, 2007 · 1. MedGenMed. 2007 Mar 5;9(1):45. Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes. Hollander PA(1). Author information: (1)Baylor University Medical Center, Endocrinology Center, Dallas, Texas, USA. [email protected] Many patients with diabetes fail to meet recommended glycemic goals regardless of the recognition of optimal glycemic …Author: Priscilla A. Hollander
https://www.researchgate.net/publication/286554041_Development_of_the_ExuberaR_Insulin_Pulmonary_Delivery_System
The aim of this study was to determine whether premeal pulmonary delivery of rapid-acting, dry-powder insulin (Exubera) plus Ultralente could provide glycemic control comparable to a conventional ...
https://link.springer.com/chapter/10.1007%2F978-1-4614-9524-6_21
Feb 04, 2014 · Abstract. Development of Exubera® (insulin powder for inhalation) presented numerous challenges as a first-in-class product. These challenges included developing (a) the first room temperature stable insulin formulation, (b) a spray-drying process to produce a fine respirable powder with the physical attributes needed for efficient aerosolization, (c) a filling and packaging process …Author: Cynthia L. Stevenson, David B. Bennett
https://www.uptodate.com/contents/inhaled-insulin-therapy-in-diabetes-mellitus
Pfützner A, Forst T. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism. Expert Opin Drug Deliv 2005; 2:1097. Brain J, Finch GL, Rice RJ, et al. Trough insulin levels in bronchoalveolar lavage following inhaltion of human insulin (Exubera) in patients with diabetes mellitus.
https://www.liebertpub.com/doi/10.1089/dia.2007.0222
The Exubera ® system (Pfizer, New York, NY/Nektar Therapeutics, San Carlos, CA) is an integration of five major new technologies: protein formulation, powder processing, powder filling, drug packaging, and delivery device. The product provides a simple interface, where the patient interacts only with the delivery device and powder packaging.Author: Nancy J. Harper, Steven Gray, Jennifer De Groot, Joann M. Parker, Negar Sadrzadeh, Carlos Schuler, J...
Searching for Exubera Pulmonary Insulin Delivery System?
You can just click the links above. The data is collected for you.
